Olink Holding AB (publ)
OLK
株式のランク
#4803
Olink Holding AB (publ) offers a comprehensive suite of products and services... Olink Holding AB (publ) offers a comprehensive suite of products and services tailored for life science research institutions, including academic bodies, government entities, biopharmaceutical companies, and biotechnology firms. The company's product lines include Olink Explore, which is designed to aid research in critical areas such as cardiovascular and metabolic health, oncology, neurology, and inflammation. Additionally, it features the Olink Target product line and the Olink Focus product line, the latter providing bespoke solutions for clients who have already pinpointed specific proteins or protein signatures for their studies. Beyond these, Olink supplies the Signature Q100, a dedicated platform for qPCR (quantitative Polymerase Chain Reaction) readouts. Its service portfolio encompasses Olink Analysis, offering end-to-end support from study design and expert consultation to sample preparation, assay execution, and stringent quality control of data, complemented by bioinformatics services. For data management and analysis, Olink provides the normalized protein expression (NPX) Manager, a specialized software tool enabling users to import data, validate its quality, and normalize findings in preparation for statistical analysis. Furthermore, Olink Insight serves as a cloud-based platform for visualizing and statistically analyzing NPX data. Olink Holding AB (publ) markets and sells its offerings worldwide through its proprietary direct sales force, reaching customers across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Established in 2004 and based in Uppsala, Sweden, the company underwent a name change in January 2021 from its former identity, Knilo HoldCo AB, to its current designation. It operates as a subsidiary of Summa Equity Holding AB.
株価
$26.08
最終同期: 2024-07-09
時価総額
$3.10B
変化（1日）
0.31%
変化（1年）
0.00%
国
SE
取引 Olink Holding AB (publ) (OLK)
カテゴリー
Healthcare
Olink Holding AB (publ)（OLK）の収益
Mar 2024 時点の収益 TTM: $171.45M
Olink Holding AB (publ) の最新の財務報告によると、現在の収益 (TTM) は $171.45M です。2022 年には $139.85M の収益があり、これは 2021 年の $94.97M と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Olink Holding AB (publ) の収益履歴（2019 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $171.45M | 0.91% |
| 2023 | $169.91M | 21.49% |
| 2022 | $139.85M | 47.25% |
| 2021 | $94.97M | 75.66% |
| 2020 | $54.07M | 29.68% |
| 2019 | $41.69M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $46.34B | 26,926.59% |
US
|
|
| $25.11B | 14,544.26% |
US
|
|
| $2.71B | 1,478.97% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 4,199.90% |
US
|
